title: [Remarkable response of bosentan, an endothelin receptor antagonist, for a patient with Eisenmenger syndrome].
authors.affiliation: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
authors.forename: Noriaki
authors.initials: N
authors.lastname: Emoto
authors.forename: Naohito
authors.initials: N
authors.lastname: Matsuo
authors.forename: Takayuki
authors.initials: T
authors.lastname: Ohnishi
authors.forename: Kazuya
authors.initials: K
authors.lastname: Miyagawa
authors.forename: Hiroki
authors.initials: H
authors.lastname: Kato
authors.forename: Naoko
authors.initials: N
authors.lastname: Iwasa
authors.forename: Akihiro
authors.initials: A
authors.lastname: Yoshida
authors.forename: Hiroya
authors.initials: H
authors.lastname: Kawai
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Hirata
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Kuroda
mesh_terms: D000368:Aged; D000077300:Bosentan; D004541:Eisenmenger Complex / Q000188:drug therapy* / Q000209:etiology; D065128:Endothelin Receptor Antagonists; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006344:Heart Septal Defects, Atrial / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan